Skip to main content
Clinical Trials/NCT05884229
NCT05884229
Recruiting
Not Applicable

The Effect of SPI (Surgical Pleth Index) - Guided Anaesthesia Versus Conventional Analgesia on Opioid Consumption Under Multimodal Analgesia in Gastric Sleeve Surgery

Iuliu Hatieganu University of Medicine and Pharmacy1 site in 1 country40 target enrollmentJanuary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intraoperative Monitoring
Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Enrollment
40
Locations
1
Primary Endpoint
Pain scores on the visual analog scale during the first 90 minutes post-operatively
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a unicentric, prospective randomised trial that aims to evaluate the role of intra-operative monitoring of nociception through SPI (Surgical Pleth Index) in guiding analgesia and reducing opioid consumption in obese patients undergoing bariatric surgery.

We aim to enrol 40 patients having laparoscopic gastric sleeve surgery in the Cluj-Napoca County Hospital. They will be randomised into two groups, one with opioid administration during surgery guided by SPI, and the other one guided by anesthetist experience. We will monitor opioid consumption, pain scores during the first 90 minutes post-operatively, hemodinamic events during surgery and the duration between reversal of neuromuscular block and extubation.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
January 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Responsible Party
Principal Investigator
Principal Investigator

Leahu Crina

MD

Iuliu Hatieganu University of Medicine and Pharmacy

Eligibility Criteria

Inclusion Criteria

  • patients scheduled to laparoscopic gastric sleeve surgery in First Surgical Clinic, Cluj-Napoca County Hospital

Exclusion Criteria

  • drugs that affect the autonomic nervous system
  • peripheral neuropathy
  • altered renal/hepatic function
  • chronic opioid use
  • use of vaso-active drugs intra-operatively

Outcomes

Primary Outcomes

Pain scores on the visual analog scale during the first 90 minutes post-operatively

Time Frame: during the first 90 minutes post-operatively

Pain scores on the visual analog scale during the first 90 minutes post-operatively

Secondary Outcomes

  • Rescue analgesia(in the first 90 minutes post-operatively)
  • Opioid consumption(during surgery)
  • Hemodinamic events(during surgery)
  • Sevoflurane concentration(during surgery)
  • Time from neuromuscular reversal to extubation(at the end of surgery)

Study Sites (1)

Loading locations...

Similar Trials